Comparison of ISQ in Implants Placed in Antral Area on Native Bone vs Regenerated Bone

NCT ID: NCT06146244

Last Updated: 2023-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

132 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-01

Study Completion Date

2019-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare ISQ values of implants placed in antral area in native bone vs regenerated bone with a follow-up at 3 months to compare values changes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The stability of dental implants is influenced by the type of bone in which the implant is placed. Native bone tends to provide better initial stability due to its density and quality, while regenerated bone, it is logical to think that it may present less stability due to the quality of the generated bone and the presence of defects in the treated area.

In this study it has been observed that after 3 months more stability is observed in the antral area, measured in ISQ resonance frequency in implants on regenerated bone, which surprises us and this result is explained in detail in said study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implant Site Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Native bone

the evolution of the SSI and its change after 3 months of placing the implant in native bone in the antral area

resonance frequency analysis

Intervention Type DEVICE

analysis of the ISQ evolution and its changes after 3 months of placing the implant in native or regenerated bone, always in the antral area

Regenerated Bone

the evolution of the SSI and its change after 3 months of placing the implant in regenerated bone in the antral area

sinus lift

Intervention Type PROCEDURE

Implant placement on grafted sinus vs antral autogenous bone

resonance frequency analysis

Intervention Type DEVICE

analysis of the ISQ evolution and its changes after 3 months of placing the implant in native or regenerated bone, always in the antral area

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sinus lift

Implant placement on grafted sinus vs antral autogenous bone

Intervention Type PROCEDURE

resonance frequency analysis

analysis of the ISQ evolution and its changes after 3 months of placing the implant in native or regenerated bone, always in the antral area

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

alveolar preservation ISQ

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients
* Total superior edentulism or antral zone edentulism
* Accepted study and signed inform consent

Exclusion Criteria

* Patients under 23 years old
* Non accepted study or signed inform consent
Minimum Eligible Age

23 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European University of Madrid

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Barbara Molina Ponte

ASSOCIATE PROFESSOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sergio Trapote Mateo, PhD

Role: STUDY_DIRECTOR

European University of Madrid

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dental Clinic of the UEM

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIPI/18/008

Identifier Type: -

Identifier Source: org_study_id